Measuring quality of life in patients with schizophrenia: An update

PharmacoEconomics

Volumn 30, Issue 3, 2012, Pages 183-195

  Awad, A George ^a,b,c   Voruganti, Lakshmi N P ^d  

^a UNIVERSITY OF TORONTO   (Canada)

^b International Society for CNS Clinical Trials and Methodology (ISCTM)   (United States)

^c HUMBER RIVER REGIONAL HOSPITAL   (Canada)

^d Department of Psychiatry   (Canada)

Author keywords

Quality of life; Quality of life rating scales; Schizophrenia.

Indexed keywords

DRUG ATTITUDE INVENTORY; GLOBAL SCALE OF ADAPTIVE FUNCTION; HEALTH CARE MANAGEMENT; HEALTH CARE POLICY; HEALTH SURVEY; HUMAN; MEDICAL DECISION MAKING; PATIENT CARE; PRIORITY JOURNAL; PSYCHOMETRY; PUBLICATION; QUALITY OF LIFE; QUALITY OF LIFE CHECKLIST SATISFACTION WITH LIFE DOMAIN SCALE; QUALITY OF LIFE INTERVIEW; QUALITY OF LIFE QUESTIONNAIRE; QUALITY OF LIFE SCALE; RATING SCALE; REVIEW; SCHIZOPHRENIA; SHORT FORM 36;

COSTS AND COST ANALYSIS; DELIVERY OF HEALTH CARE; HEALTH POLICY; HUMANS; POLICY MAKING; PSYCHOMETRICS; QUALITY OF LIFE; RESOURCE ALLOCATION; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 84857320694     PISSN: 11707690     EISSN: 11792027     Source Type: Journal    
DOI: 10.2165/11594470-000000000-00000     Document Type: Review

References (86)

1. Awad AG, Voruganti LNP, Heslegrave RJ. Measuring quality of life in patients with schizophrenia. Pharmacoeconomics 1997; 11 (1): 32-47 (Pubitemid 27032248)
2. World Health Organization. The constitution of the World Health Organization. WHO Chron 1947; 1: 29
3. Awad AG, Voruganti LNP. International research in psychosis: issues related to the assessment of quality of life. Schizophr Bull 2000; 26 (3): 557-64
4. Lehman A, Ward N, Linn L. Chronic mental patients: the quality of life issue. Am J Psychiatry 1982; 139: 1274-6
5. Ritsner M. The Distress/Protection vulnerability model of quality of life impairment syndrome. In: Ritsner M, Awad AG, editors. Quality of life impairment in schizophrenia, mood and anxiety disorders. Dordrecht: Springer, 2007: 3-20
6. Narvacz JM, Twamley EW, McKibben CL, et al. Subjective and objective quality of life in schizophrenia. Schizophr Res 2008; 98: 201-8 (Pubitemid 350235889)
7. Eak SM, Newhill CE. Psychiatric symptoms and quality of life in schizophrenia: a meta-analysis. Schizophr Bull 2007; 33: 1225-37 (Pubitemid 47347913)
8. Nadalet L, Kohl FS, Pringuey D, et al. Validation of a subjective quality of life questionnaire (S.QUA.LA) in schizophrenia. Schizophr Res 2005; 76: 73-81 (Pubitemid 40824562)
9. Auquier P, Simioni MC, Sapin C, et al. Development and validation of a patient-based health related quality of life questionnaire in schizophrenia: the S-QOL. Schizophr Res 2003; 63: 137-49 (Pubitemid 36929856)
10. Priebe S, Reininghans U, McCabe R, et al. Factors influencing subjective quality of life in patients with schizophrenia and other mental disorders: a pooled analysis. Schizophr Res 2010; 21: 251-8
11. Norman RH, Malla AK, McLean T, et al. The relationship of symptoms and level of functioning in schizophrenia to general wellbeing and the Quality of Life Scale. Acta Psychiatr Scand 2000; 102: 303-9
12. Skantze K, Malm U, Denker SJ, et al. Comparison of quality of life with standard of living in schizophrenic outpatients. Br J Psychiatry 1992; 161: 797-801
13. Awad AG, Voruganti LNP. Antipsychotics, schizophrenia and the issue of quality of life. In: Ritsner M, Awad AG, editors. Quality of life impairment in schizophrenia, mood and anxiety disorders. Dordrecht: Springer, 2007: 307-19
14. Voruganti LNP, Heselgrave RJ, Awad AG, et al. Quality of life measurement in schizophrenia: reconciling the question of subjectivity with question of reliability. Psychol Med 1998; 28: 165-72 (Pubitemid 28043578)
15. Awad AG, Voruganti LNP, Heselgrave RJ. The aim of antipsychotic medications: what are they and are they being achieved? CNS Drugs 1995; 4: 8-16
16. Calman KC. Quality of life in cancer patients: an hypothesis. J Med Ethics 1984; 10: 124-7
17. Ware Jr JE. The SF-36 health survey in quality of life and pharmacoeconomics in clinical trials. In: Spilker B, editor. Quality of life and pharmacoeconomics in clinical trials. Philadelphia (PA): Lippincott-Raven, 1996: 337-45
18. Wood S, William JI. Reintegration to normal living as a proxy to quality of life. J Chronic Dis 1987; 40: 497-9
19. Awad AG, Voruganti LNP, Heslegrave RJ. Preliminary validation of a conceptual model to assess quality of life in schizophrenia. Qual Life Res 1997; 6: 21-6 (Pubitemid 27110091)
20. Zissi A, Barry MU, Cochrane R. A meditational model of quality of life for individuals with severe mental health problems. Psychol Med 1998; 28: 1221-30 (Pubitemid 28458478)
21. Voruganti LNP, Awad AG, Parker G, et al. Cognition, functioning and quality of life in schizophrenia treatment: results of a one year randomized controlled trial of olanzepine and quetiapine. Schizophr Res 2007; 96: 146-55 (Pubitemid 47494646)
22. Skantze K, Malm U. A new approach to facilitation of working alliances based on patients' quality of life goals. Nord J Psychiatry 1994; 48: 37-55
23. Lehman AF. A quality of life interview for the chronically mentally ill. Eval Program Plan 1988; 11: 51-62
24. Sainfort F, Becker M, Diamond R. Judgements of quality of life of individuals with severe mental disorders: patient selfreport versus provider perspectives. Am J Psychiatry 1996; 153: 497-502 (Pubitemid 26113313)
25. Skantze K. Subjective quality of life and standard of living: a 10-year follow-up of outpatients with schizophrenia. Acta Psychiatr Scand 1998; 98 (5): 390-9 (Pubitemid 28529684)
26. Ritsner M, Gibel A, Ratner Y, et al. Determinants of changes in perceived quality of life in the course of schizophrenia. Qual Life Res 2006; 15: 515-26
27. Gorna K, Jaracz K, Rybakowski F, et al. Determinants of objective and subjective quality of life in first time admission schizophrenic patients in Poland: a longitudinal study. Qual Life Res 2008; 17 (2): 237-47
28. Bengtsson-Tops A, Hansson L, Sandlunds M, et al. Subjective versus interviewer assessment of global quality of life among persons with schizophrenia living in the community: a Nordic multicentre study. Qual Life Res 2005; 14: 221-9 (Pubitemid 40249096)
29. Ruggeri M, Bisoffi G, Fontecedro L, et al. Subjective and objective dimensions of quality of life in psychiatric patients - a factor analytical approach: the South Verona Outcome Project 4. Br J Psychiatry 2001; 178: 268-75 (Pubitemid 32183611)
30. Wehmeier PM, Kluge M, Schacht A, et al. Correlation of physician and patient related quality of life during antipsychotic treatment in outpatients with schizophrenia. Schizophr Res 2007; 91: 178-86
31. Awad AG, Voruganti LNP. The subjective/objective dichotomy: relevance to nosology, research and management. In: Gaebel W, editor. Zukunftsperspekiven in psychiatries und psychotherapie. Darnstadt: Stienkopff verlog, 2002: 21-7
32. Najman JM, Levine S. Evaluating the impact of medical care and technologies on the quality of life: a review and critique. Soc Sci Med 1981; 15: 107-15 (Pubitemid 12204083)
33. Awad AG, Voruganti LNP. Impact of atypical antipsychotics on quality of life in patients with schizophrenia. CNS Drugs 2004; 18: 877-93 (Pubitemid 39612017)
34. Stein LT, Test MA. Alternative to mental health treatment: I. Conceptual model, treatment program and clinical evaluation. Arch Gen Psychiatry 1980; 37: 392-197
35. Malm U, May PRA, Deneker SJ. Evaluation of the quality of life of the schizophrenic outpatient: a checklist. Schizophr Bull 1981; 7: 477-87 (Pubitemid 11025916)
36. Baker F, Intagliata J. Quality of life in the evaluation of community support systems. Eval Program Plann 1982; 5: 69-79
37. Bigelow DA, Brodsky G, Steward L, et al. The concept and measurement of quality of life as a dependent variable in evaluation of mental health services. In: Stahler GJ, Tash WR, editors. Innovative approaches to mental health evaluation. New York: Academic Press, 1982: 345-66
38. Awad AG. Subjective response to neuroleptics in schizophrenia. Schizophr Bull 1993; 19: 609-18 (Pubitemid 23272627)
39. Hogan TP, Awad AG. Subjective response to neuroleptics and outcomes in schizophrenia: a re-examination comparing two measures. Psychol Med 1992; 22: 347-52
40. Rosen A, Pavlovic H, Parker G. The life skills profile: a measure assessing function and disability in schizophrenia. Schizophr Bull 1989; 325-34
41. Heinrichs DW, Hanlon TE, Carpenter WT. The quality of life scale: an instrument for rating the schizophrenic deficit symptoms. Schizophr Bull 1984; 388-98
42. Stuart E, Wykes T. Assessment schedules for chronic psychiatric patients. Psychol Med 1987; 17: 485-93
43. Becker M, Diamond R, Sainfort F. A new patient focused index for measuring quality of life in persons with severe and persistent mental illness. Qual Life Res 1993; 2: 239-51 (Pubitemid 23282327)
44. Endicott J, Spitzer Rl, Fleiss JL, et al. The Global Assessment Scale: a procedure for measuring overall severity of psychiatric disturbance. Arch Gen Psychiatry 1976; 33: 766-71
45. McDowell I, Newell C. Measuring health: a guide to rating scales and questionnaires. New York: Oxford University Press, 1987
46. Bergner M, Bobbit RA, Carter WB, et al. The Sickness Impact Profile: development and final revision of a health status measure. Med Care 1981; 19: 787-805 (Pubitemid 11021288)
47. McHorney CA, Ware Jr JE, Lu R, et al. The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions and reliability across diverse patient groups. Med Care 1994; 32: 40-66
48. Chambers LW. The McMaster health index questionnaire. In: Spilker B, editor. Quality of life and pharmacoeconomics in clinical trials. Philadelphia (PA): Lippincott- Raven, 1996: 267-79
49. Kawata A, Revicki D. Reliability and validity of the social integration survey (SIS) in patients with schizophrenia. Qual Life Res 2008; 17: 123-35
50. Boyer L, SimeoniMC, Loundou A, et al. The development of the S-QOL 18: a shortened quality of life questionnaire for patients with schizophrenia. Schizophr Res 2010; 121: 241-50
51. Voruganti LNP, Awad AG. Personal evaluation of transition in treatment (PETiT): a scale to measure subjective aspects of antipsychotic drug therapy in schizophrenia. Schizophr Res 2002; 56: 37-46 (Pubitemid 34655466)
52. Oliver JPJ, Huxley PJ, Priebe S, et al. Measuring the quality of life of severely mentally ill people using the Lancashire Quality of Life Profile. Soc Psychiatry Psychiatr Epidemiol 1997; 32: 76-83 (Pubitemid 27075694)
53. Oliver JPJ. How to use quality of life measures in individual care. In: Priebe S, Oliver JPJ, Kaiser W, editors. Quality of life and mental health care. Petersfield: Wrightson Biomedical Publishing, 1999: 81-105
54. Kusel Y, Laugharne R, Perrington S, et al. Measurement of quality of life in schizophrenia: a comparison of two scales. Soc Psychiatry Psychiatr Epidemiol 2007; 42: 819-23 (Pubitemid 47470756)
55. Priebe S, Huxley P, Knight S, et al. Application and results of the Manchester Short Assessment quality of life (MANSA). In: Priebe S, Oliver J, Kaiser W, editors. Quality of life and mental health care. Petersfield: Wrightson Biomedical Publishing, 1999: 155-7
56. Wilkinson G, Hesdon B, Wild D, et al. Self-report quality of life measure for people with schizophrenia: SQLS. Br J Psychiatry 2000; 177: 42-6 (Pubitemid 30450663)
57. Kaneda Y, Imakura A, Fujii A, et al. Schizophrenia quality of life: validation of the Japanese version. Psychiatry Res 2001; 113: 107-13
58. Luo N, Seng BK, Xie F, et al. Psychometric evaluation of the schizophrenia quality of life scale (SQLS) in English and Chinese speaking patients in Singapore. Qual Life Res 2008; 17: 115-22
59. Kolotkin RL, Crosby RD, Corey-Lisle PK, et al. Performance of weight-related measure of quality of life in a psychiatric sample. Qual life Res 2006; 15: 587-96 (Pubitemid 43843967)
60. Awad AG, Voruganti LNP. Body weight, image and selfesteem evaluation questionnaire development and validation of a new scale. Schizophr Res 2004; 70: 63-7 (Pubitemid 38916629)
61. Atkinson M, Zibin S, Chuang H. Characterising quality of life among patients with chronic mental illness: a critical examination of self-report methodology. Am J Psychiatry 1997; 154: 99-105 (Pubitemid 27020200)
62. National Institutes of Health. Patient Reported Outcomes Measurement Information System (PROMIS) [online]. Available from URL: http://www.nihpromis. org [Accessed 2008 Feb 1]
63. Greenhalgh J, Long AF, Flynn R. The use of patient reported outcome measures in routine clinical practice: lack of impact or lack of theory? Soc Sci Med 2005; 60: 833-43 (Pubitemid 39574779)
64. Lauer G. Concepts of quality of life in mental health care. In: Priebe S, Oliver J, Kaiser W, editors. Quality of life and mental health care. Petersfield: Wrightson Biomedical Publishing Ltd, 1999: 1-18
65. Revicki D. Pharmacoeconomic studies of atypical antipsychotics drugs for the treatment of schizophrenia. Schizophr Res 1999; 35 Suppl.: S101-9 (Pubitemid 29133031)
66. Luo N, Seng BK, Thumboo J, et al. A study of the construct validity of the Health Utilities Index Mark 3 (HUI3) in patients with schizophrenia. Qual Life Res 2006; 15 (5): 889-98 (Pubitemid 43800760)
67. Petrou S, Johnson S, Wolke D, et al. Economic costs and preference-based health-related quality of life outcomes associated with childhood psychiatric disorders. Br J Psychiatry 2010; 197: 395-404
68. Awad AG, Voruganti LNP. Cost-utility analysis in schizophrenia. J Clin Psychiatry 1999; 60 Suppl. 3: 22-6 (Pubitemid 29106679)
69. Voruganti LNP, Awad AG, Oyewumi LK, et al. Assessing health utilities in schizophrenia: a feasibility study. Pharmacoeconomics 2000; 17 (3): 273-86 (Pubitemid 30214634)
70. Hooker C, Park S. Emotion processing and its relationship to social functioning in schizophrenic patients. Psychiatry Res 2002; 112: 41-50
71. Wise RA. Neurobiology of addiction. Curr Opin Neurobiol 1996; 6: 243-51 (Pubitemid 26168484)
72. Adinoff B. Neurobiologic processes in drug reward and addiction. Harv Rev Psychiatry 2004; 12 (6): 305-20 (Pubitemid 40144218)
73. Goff DC. New insight into clinical response in schizophrenia: fromdopamine D2 receptor occupancy to patients' quality of life. Am J Psychiatry 2008; 165: 940-3
74. Awad AG, Voruganti LNP. Neuroleptic dysphoria, comorbid drug abuse in schizophrenia and the emerging science of subjective tolerability. J Dual Diagnosis 2005; 2: 83-94
75. Thornicroft G, Tansella M, Becker T, et al. The personal impact of schizophrenia in Europe. Schizophr Res 2004; 69: 125-32 (Pubitemid 38721411)
76. Voruganti LNP, Awad AG. Subjective and behavioural consequences of striatal dopamine depletion in schizophrenia: findings from an in vivo SPECT study. Schizophr Res 2006; 88: 179-86 (Pubitemid 44693241)
77. deHaan L, Lavalaye J, Linszen D, et al. Subjective experiences and striatal dopamine D2 receptor occupancy in patients with schizophrenia stabilized by olanzepine or risperidal. Am J Psychiatry 2000; 157: 1019-20 (Pubitemid 30412360)
78. Bowie C, Reichenberg A, Patterson T, et al. Determinants of real-world functional performance in schizophrenia subjects: correlations with cognition, functional capacity and symptoms. Am J Psychiatry 2006; 163: 418-25 (Pubitemid 44469383)
79. Yamauchi K, Hirofumi A, Masahito T, et al. Predictors of subjective and objective quality of life in patients with schizophrenia. Psychiatr Clin Neurosci 2008; 62: 404-11
80. Hwang S, Lee JY, Cho SJ, et al. The model of the relationships among the predictors of quality of life in chronic stage of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2009; 33 (7): 1113-8
81. Heselgrave RJ, Awad AG, Voruganti LNP. The influence of neurocognitive deficits and symptoms on quality of life in schizophrenia. J Psychiatry Neurosci 1997; 22: 235-43 (Pubitemid 127488587)
82. Moritz S, Ferhali S, Naber D. Memory and attention performance in psychiatric patients: lack of correspondence between clinician-rated and patient-rated functioning with neuropsychological test results. J Int Neuropsychol Soc 2004; 10: 623-33 (Pubitemid 39077202)
83. Alptekin K, Akvardar Y, Akdede B, et al. Is quality of life associated with cognitive impairment in schizophrenia? Prog Neuropsychopharmacol Biol Psychiatry 2005; 29: 239-44 (Pubitemid 40202909)
84. Tomotake M, Kaneda Y, Iga J, et al. Subjective and objective measures of quality of life have different predictors for people with schizophrenia. Psychol Rep 2006; 99: 477-87 (Pubitemid 44831811)
85. Huppert JD, Weiss KA, Lim R, et al. Quality of life in schizophrenia: contributions of anxiety and depression. Schizophr Res 2001; 51: 171-80 (Pubitemid 32772850)
86. TestMA, Greenberg JS, Long JD, et al. Construct validity of a measure of subjective satisfaction with life of adults with serious mental illness. Psychiatr Serv 2005; 56: 292-300 (Pubitemid 40333561)